Treatment for Older Lymphoma Patients
Published: 2017-09-13 |
Author: Carlos Harrison |
Source: Cancer Therapy Advisor
Because of factors such as advances in health care and the decreasing overall incidence of cancer, the number of people age 65 and older around the world is expected to be 1.6 billion by 2050, which is twice the size of the current population at that age. That increase will bring a "tsunami" of cancer cases in older patients, researchers say, which pose an array of problematic treatment challenges, including comorbidities and toxicities, that are complicated by age of the patient.
Recognizing the rising effect of the surge and the need to address the specific needed of older patients, a number of practitioners are signaling the need for a multifaceted approach to treatment, along with increased inclusion of seniors in clinical trials.
In a review published just this month, Dominigue Bron, MD, head of the hematology department at the Institute Jules Bordet in Belgium, and Pierre Soubeyran, MD, head of clinical research and coordinator of the hematological research group at the Bergonie Cancer Institute in France, focused on older lymphoma patients. "The choice for an optimal treatment in older lymphoma patients is a real challenge for hemato-oncologists," they wrote. They have to treat a potentially curative lymphoma, and concomitantly protect their patients from unacceptable toxicities."